Materials and chemicals
Biomass can be used to produce chemicals, fibres, pigments and plastics. These products are either identical to their petroleum-based counterparts or have completely new properties. Biorefineries will play a key role in the transition to a bioeconomy. There is great expectation placed on the potential ability to convert the countless carbon compounds in biomass into chemicals and material components.
Article - 11-Mar-2013
Trenzyme GmbH in Konstanz offers services and products in the fields of genomics and proteomics. The company specialises in contract research and custom R&D services and is also working on new and improved products and processes. The company recently developed a new method for the rapid identification of optimal expression conditions for recombinant proteins.
Article - 25-Feb-2013
Microalgae have played an important role as animal feed or food supplements for decades. They can also produce complex chemical compounds. This so-called material use of microalgae is already a major economic sector. However, when it comes to algal biotechnology, they are almost universally seen as just energy sources.
Article - 18-Feb-2013
At its New Year reception Biberach University of Applied Sciences outlined the universitys success the establishment of its biotechnology programme is going smoothly and student interest remains steady. Biberach also has a successful track record of acquiring third-party funding and has established new national and international cooperations.
Article - 04-Feb-2013
“capmatch medical” was specifically designed for young medical device and biotech companies that are seeking capital from investors in Europe. Combined with professional coaching and process management, capmatch medical’s matching approach improves the chances of successful matchmaking between companies and dedicated investors.
Article - 21-Jan-2013
The Institute of Biological Process Engineering (IBV) at the Mannheim University of Applied Sciences has been focusing on sustainable products and methods modelled on nature for 25 years. The institute will celebrate its 25th anniversary on the university campus at the end of the 2013 summer semester.
Article - 31-Dec-2012
Regenerative medicine is increasingly making use of siRNA to turn off proteins that prevent the application of regenerative therapies. Researchers at the NMI in Reutlingen develop siRNA technologies that have the potential to prevent the development of fibroses, the encapsulation of implants and improve the regeneration of nerves.
Article - 10-Dec-2012
MicroMol GmbH carries out microbiological, molecular and cell biological analyses, is active in research and development, performs validations and produces and sells laboratory products for the life sciences industry. This brief description reflects a broad product and service portfolio that addresses a wide range of different clients, including companies in the pharmaceutical and chemical industries and in the medical technology, industrial biotechnology and nutrition sectors.
Article - 29-Oct-2012
Industry is being greened. The EU has put in place schemes to boost the bioeconomy Germany Finland Norway Denmark and the Netherlands are working hard on bioeconomy strategies. Even regional stakeholders are developing concepts aimed at supporting the bioeconomy. Things are moving in the right direction.